期刊文献+
共找到8篇文章
< 1 >
每页显示 20 50 100
Associations between thromboxane A synthase 1 gene polymorphisms and the risk of ischemic stroke in a Chinese Han population 被引量:6
1
作者 Lei Li Zhi-yi He +2 位作者 Yan-zhe Wang Xu Liu Li-ying Yuan 《Neural Regeneration Research》 SCIE CAS CSCD 2018年第3期463-469,共7页
Thromboxane A synthase 1 (TBXAS1) catalyses the synthesis of thromboxane A2 (TXA2), which plays an important role in the pathogenesis of ischemic stroke. Thus, the TBXAS1 gene was investigated as a candidate gene ... Thromboxane A synthase 1 (TBXAS1) catalyses the synthesis of thromboxane A2 (TXA2), which plays an important role in the pathogenesis of ischemic stroke. Thus, the TBXAS1 gene was investigated as a candidate gene involved in the formation of atherosclerosis. This case-control study collected peripheral blood specimens and clinical data of 370 ischemic stroke patients and 340 healthy controls in the Northern Chinese Han population from October 2010 to May 2011. Two TBXAS1 single-nucleotide polymorphisms, rs2267682 and rs10487667, were analyzed using a SNaPshot Multiplex sequencing assay to explore the relationships between the single-nucleotide polymorphisms in TBXAS1 and ischemic stroke. The TT genotype frequency and T allele frequency of rs2267682 in the patients with ischemic stroke were significantly higher than those in the controls (P 〈 0.01 and P = 0.02). Furthermore, compared with the GG + GT genotype, the TT rs2267682 genotype was associated with increased risk of ischemic stroke (odds ratio (OR) = 1.80, 95% confidence interval (CI): 1.16–2.79, P 〈 0.01). Multivariate logistic analysis with adjustments for confounding factors revealed that rs2267682 was still associated with ischemic stroke (OR = 1.94,95% CI : 1.13–3.33, P = 0.02). The frequency of the T-G haplotype in the patients was significantly higher than that in the controls according haplotype analysis (OR = 1.49, 95% CI: 1.10–2.00, P 〈 0.01). These data reveal that the rs2267682 TBXAS1 polymorphism is associated with ischemic stroke. The TT genotype of TBXAS1 and T allele of rs2267682 increase susceptibility to ischemic stroke in this Northern Chinese Han population. The protocol has been registered with the Chinese Clinical Trial Registry (registration number: ChiCTR-COC-17013559). 展开更多
关键词 nerve regeneration brain injury ischemic stroke thromboxane A synthase 1 single nucleotide polymorphism case-control study thromboxane A2 Chinese Han population HAPLOTYPE large-artery atherosclerosis small-artery occlusion neural regeneration
下载PDF
Association of G-protein coupled purinergic receptor P2Y2 with ischemic stroke in a Han Chinese population of North China 被引量:2
2
作者 Li-Ying Yuan Zhi-Yi He +1 位作者 Lei Li Yan-Zhe Wang 《Neural Regeneration Research》 SCIE CAS CSCD 2019年第3期506-512,共7页
The G-protein-coupled purinergic receptor P2Y2(P2RY2) plays an important role in the mechanism of atherosclerosis, which is relevant to ischemic stroke. This retrospective case-control study aimed to assess the relati... The G-protein-coupled purinergic receptor P2Y2(P2RY2) plays an important role in the mechanism of atherosclerosis, which is relevant to ischemic stroke. This retrospective case-control study aimed to assess the relationship between P2RY2 gene polymorphisms and ischemic stroke risk in the northern Han Chinese population. In this study, clinical data and peripheral blood specimens were collected from 378 ischemic stroke patients and 344 controls. The ischemic stroke participants were recruited from the First Affiliated Hospital of China Medical University and the First Affiliated Hospital of Liaoning Medical University. The controls were recruited from the Health Check Center at the First Affiliated Hospital of China Medical University. Ischemic stroke patients were divided into two subgroups according to the Trial of ORG 10172 in Acute Stroke Treatment(TOAST) classification: large-artery atherosclerosis(n = 178) and small-artery occlusion(n = 200) strokes. All subjects were genotyped for three single nucleotide polymorphisms(rs4944831, rs1783596, and rs4944832) in the P2RY2 gene using peripheral venous blood samples. The distribution of the dominant rs4944832 phenotype(GG vs. GA+AA) differed significantly between small-artery occlusion patients and control subjects(odds ratio(OR) = 1.720, 95% confidence interval(CI): 1.203–2.458, P < 0.01). Multivariable logistic regression analysis revealed that the GG genotype of rs4944832 was significantly more prevalent in small-artery occlusion patients than in control subjects(OR = 1.807, 95% CI: 1.215–2.687, P < 0.01). The overall distribution of the haplotype established by rs4944831-rs1783596-rs4944832 was significantly different between ischemic stroke patients and controls(P < 0.01). In ischemic stroke patients, the frequency of the G-C-G haplotype was significantly higher than in control subjects(P = 0.028), whereas the frequency of the T-C-A haplotype was lower than in control subjects(P = 0.047). These results indicate that the G-C-G haplotype of P2RY2 is a susceptibility haplotype for ischemic stroke. In addition, the GG genotype of rs4944832 may be associated with the development of small-artery occlusion in the northern Han Chinese population. The study protocol was approved by the Ethics Committee of the First Affiliated Hospital of China Medical University on February 20, 2012(No. 2012-38-1) and the First Affiliated Hospital of Liaoning Medical University, China, on March 1, 2013(No. 2013-03-1). All participants gave their informed consent. This trial was registered with the ISRCTN Registry(ISRCTN11439124) on October 24, 2018. Protocol version(1.0). 展开更多
关键词 nerve REGENERATION P2RY2 GENE ischemic stroke single nucleotide polymorphism CASE-CONTROL study haplotype northern Han Chinese POPULATION large-artery atherosclerosis small-artery occlusion hypertension candidate GENE neural REGENERATION
下载PDF
脂蛋白相关磷脂酶A_2对大动脉粥样硬化型脑梗死病情进展的预测价值 被引量:9
3
作者 王惠 马先军 +2 位作者 董万利 宁倩 朱孟慧 《脑与神经疾病杂志》 2017年第7期407-410,共4页
目的探讨大动脉粥样硬化(LAA)型脑梗死病情进展与脂蛋白相关磷脂酶A_2(Lp-PLA_2)的相关性。方法收集2015年4月—2016年7月本科收治的急性LAA型脑梗死患者80例。采用斯堪地那维亚卒中量表(SSS)评估患者病情是否发生进展,检测患者的血浆... 目的探讨大动脉粥样硬化(LAA)型脑梗死病情进展与脂蛋白相关磷脂酶A_2(Lp-PLA_2)的相关性。方法收集2015年4月—2016年7月本科收治的急性LAA型脑梗死患者80例。采用斯堪地那维亚卒中量表(SSS)评估患者病情是否发生进展,检测患者的血浆同型半胱氨酸(Hcy)、Lp-PLA_2,并收集颅内外血管相关检查的结果。对LAA型进展性卒中的预测因素进行分析。结果血浆Hcy和Lp-PLA_2水平与LAA型脑梗死病情进展相关,对LAA型脑梗死病情进展有预测作用。结论高水平的血浆Hcy和LpPLA_2是LAA型脑梗死病情进展的独立预测因素。 展开更多
关键词 大动脉粥样硬化型脑梗死 脂蛋白相关磷脂酶A2 进展性卒中 预测因素
下载PDF
大动脉粥样硬化型脑梗死病情进展的预测因素 被引量:8
4
作者 王惠 马先军 +2 位作者 卞光荣 朱孟慧 宁倩 《吉林医学》 CAS 2016年第5期1075-1078,共4页
目的:探讨大动脉粥样硬化(Large Artery Atherosclerosis,LAA)型脑梗死病情进展的预测因素。方法:选取收治的急性LAA型脑梗死患者173例。采用斯堪地那维亚卒中量表(Scandinavian Stroke Scale,SSS)评估患者病情是否发生进展,收集患者的... 目的:探讨大动脉粥样硬化(Large Artery Atherosclerosis,LAA)型脑梗死病情进展的预测因素。方法:选取收治的急性LAA型脑梗死患者173例。采用斯堪地那维亚卒中量表(Scandinavian Stroke Scale,SSS)评估患者病情是否发生进展,收集患者的病史资料、实验室及影像学检查结果。对LAA型进展性卒中的发生率及预测因素进行分析。结果:LAA型进展性卒中的发生率为23.1%;入院时血压、H型高血压、高同型半胱氨酸血症(Hyperhomocysteinemia,HHcy)、颅内外动脉狭窄与LAA型脑梗死病情进展相关;入院时收缩压、H型高血压、HHcy、颅内动脉狭窄对LAA型脑梗死病情进展有显著预测作用。结论:H型高血压、颅内动脉狭窄、入院时收缩压及HHcy是LAA型脑梗死病情进展的独立预测因素。 展开更多
关键词 大动脉粥样硬化型脑梗死 进展性卒中 预测因素
下载PDF
卒中发病前高血压控制情况与缺血性脑卒中分型的相关性分析 被引量:6
5
作者 曹琴琴 蒋蔚 +2 位作者 华烨 蒋思明 马涛 《实用临床医药杂志》 CAS 2021年第11期39-42,共4页
目的探讨缺血性脑卒中合并高血压患者发病前高血压治疗控制情况与缺血性脑卒中分型之间的关系。方法回顾性分析681例大动脉粥样硬化(LAA)型或小血管闭塞(SVO)型缺血性脑卒中合并高血压患者的临床资料,采用多因素Logistic回归分析法分析... 目的探讨缺血性脑卒中合并高血压患者发病前高血压治疗控制情况与缺血性脑卒中分型之间的关系。方法回顾性分析681例大动脉粥样硬化(LAA)型或小血管闭塞(SVO)型缺血性脑卒中合并高血压患者的临床资料,采用多因素Logistic回归分析法分析卒中发病前高血压控制情况与LAA型缺血性脑卒中之间的关系。结果卒中发病前高血压未控制患者(OR=1.607,95%CI为1.102~2.343)发生LAA型缺血性脑卒中的可能性更大。超重(OR=1.498,95%CI为1.066~2.105)、糖尿病(OR=1.803,95%CI为1.215~2.674)、男性(OR=1.804,95%CI为1.190~2.733)患者发生LAA型缺血性脑卒中的可能性更大。结论规范化治疗并控制高血压可能会降低LAA型缺血性脑卒中的发生率。 展开更多
关键词 高血压 缺血性脑卒中 大动脉粥样硬化型缺血性脑卒中 小血管闭塞型缺血性脑卒中
下载PDF
银丹心脑通软胶囊治疗大动脉粥样硬化性脑梗死恢复期患者的临床效果 被引量:6
6
作者 吴晓平 孙宏丽 《临床医学研究与实践》 2020年第35期160-162,共3页
目的分析银丹心脑通软胶囊治疗大动脉粥样硬化性脑梗死恢复期患者的临床效果。方法选择我院2018年1月到2019年12月收治的88例大动脉粥样性硬化脑梗死恢复期患者作为研究对象,根据治疗方法将其分为对照组与研究组,每组44例。对照组接受... 目的分析银丹心脑通软胶囊治疗大动脉粥样硬化性脑梗死恢复期患者的临床效果。方法选择我院2018年1月到2019年12月收治的88例大动脉粥样性硬化脑梗死恢复期患者作为研究对象,根据治疗方法将其分为对照组与研究组,每组44例。对照组接受常规治疗,研究组在对照组基础上接受银丹心脑通软胶囊治疗。比较两组患者的临床疗效。结果治疗后,研究组的MRS评分低于对照组,Barthel评分高于对照组(P<0.05);治疗后,研究组的NIHSS评分低于对照组,SS-QOL评分高于对照组(P<0.05);治疗后,两组的血清CRP与Chemerin水平均降低,且研究组低于对照组(P<0.05);研究组的治疗总有效率明显高于对照组(P<0.05)。结论银丹心脑通软胶囊治疗大动脉粥样硬化性脑梗死效果显著,能够减轻患者的神经功能损伤,值得临床进一步推广运用。 展开更多
关键词 大动脉粥样性硬化脑梗死 银丹心脑通软胶囊 神经功能 生活质量
下载PDF
大动脉粥样硬化型脑梗死临床结局预测因素的短期随访分析 被引量:1
7
作者 王惠 马先军 杨博峰 《华西医学》 CAS 2022年第8期1181-1187,共7页
目的探讨大动脉粥样硬化(large artery atherosclerosis,LAA)型脑梗死临床进展及短期预后的预测因素。方法纳入2016年1月-2019年5月在连云港市中医院神经内科住院治疗的急性LAA型脑梗死患者。入院时收集患者病史,评估神经功能缺损程度,... 目的探讨大动脉粥样硬化(large artery atherosclerosis,LAA)型脑梗死临床进展及短期预后的预测因素。方法纳入2016年1月-2019年5月在连云港市中医院神经内科住院治疗的急性LAA型脑梗死患者。入院时收集患者病史,评估神经功能缺损程度,测量血压,检测血糖、血脂、血浆同型半胱氨酸、脂蛋白相关磷脂酶A2(lipoprotein-associated phospholipase A2,Lp-PLA2),并收集颅内外血管相关检查的结果。在发病72 h内,采用斯堪地那维亚卒中量表(Scandinavian Stroke Scale,SSS)判断患者病情是否发生进展,采用改良Rankin量表评估发病30 d短期预后,分析LAA型脑梗死临床进展及短期预后的相关因素。结果最终纳入100例患者。根据发病72 h内SSS评估结果分为进展组27例,非进展组73例。两组性别、年龄差异无统计学意义(P>0.05)。根据发病30 d时改良Rankin量表评估结果分为预后不良组31例,预后良好组69例。两组性别、年龄差异无统计学意义(P>0.05)。Logistic回归分析结果显示,血浆Lp-PLA2[比值比(odds ratio,OR)=1.013,95%置信区间(confidence interval,CI)(1.007,1.018),P<0.001]、SSS评分[OR=0.910,95%CI(0.842,0.985),P=0.019]、高血压病史[OR=5.527,95%CI(1.241,24.613),P=0.025]是患者72 h内病情进展的预测因素;SSS评分[OR=0.849,95%CI(0.744,0.930),P<0.001]、颈动脉狭窄[OR=9.536,95%CI(1.395,65.169),P=0.021]及进展性卒中[OR=8.873,95%CI(1.937,40.640),P=0.005]是LAA型脑梗死短期预后的预测因素。结论既往高血压病史和高水平血浆Lp-PLA2能够预测脑梗死的早期进展;颈动脉狭窄和进展性卒中能够预测脑梗死急性期的不良结局;入院时神经功能评分对早期及急性期的短期不良结局均有预测作用。 展开更多
关键词 大动脉粥样硬化型脑梗死 临床结局 预测因素
原文传递
维生素D与急性大动脉粥样硬化型脑梗死的关系 被引量:2
8
作者 肖雅娟 冯利东 +1 位作者 吴跃华 吴捷 《神经疾病与精神卫生》 2017年第2期89-92,共4页
目的探讨血清维生素D与急性大动脉粥样硬化型脑梗死的关系及其对病情严重程度、近期神经功能改善程度的影响。方法选择2014年6月~2016年5月就诊包头市第四医院神经内科发病在24h内的大动脉粥样硬化型脑梗死患者100例为试验组,所有患... 目的探讨血清维生素D与急性大动脉粥样硬化型脑梗死的关系及其对病情严重程度、近期神经功能改善程度的影响。方法选择2014年6月~2016年5月就诊包头市第四医院神经内科发病在24h内的大动脉粥样硬化型脑梗死患者100例为试验组,所有患者入院当天、治疗第14天采用美国国立卫生研究院卒中量表(NIHSS)评分;选择同期门诊健康体检者60人为对照组,比较两组患者血维生素D水平;根据入院时NIHSS评分将试验组患者分为重度、中度和轻度神经功能缺损组,根据血清维生素D水平将试验组患者再次分为维生素D充足组、不足组和缺乏组;进一步分析入院时血清维生素D水平与病情严重程度及近期神经功能改善程度的关系。结果(1)试验组血清维生素D水平明显低于对照组[(13.97±1.32)阻g/L比(21.62±0.89)斗g/L],差异有统计学意义(P-0.018);(2)重度神经功能缺损组维生素D水平明显低于中度组[(9.21±0.73)μg/L比(12.24±1.02)μg/L]和轻度组[(15.01±0.98)斗g/L],差异均有统计学意义fP〈0.01);相关性分析显示血清维生素D与NIHSS评分呈负相关(r=-1.892,P=0.046);(3)治疗14d维生素D充足组神经功能改善程度(ANIHSS)明显高于维生素D不足组和维生素D缺乏组(肚5.47,P=0.01)。结论维生素D水平在大动脉粥样硬化型脑梗死中明显降低,病情越重,水平越低,并且与近期神经功能改善程度密切相关。 展开更多
关键词 维生素D 大动脉粥样硬化型脑梗死 神经功能
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部